Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
2(29%)
Results Posted
40%(2 trials)

Phase Distribution

Ph phase_2
3
43%
Ph phase_1
2
29%
Ph early_phase_1
2
29%

Phase Distribution

4

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
2(28.6%)
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
3(42.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(5)

Detailed Status

Completed5
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 12 (28.6%)
Phase 12 (28.6%)
Phase 23 (42.9%)

Trials by Status

completed571%
recruiting229%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
OTHER
Total Trials
7